Structure-Guided Discovery of Novel, Potent, and Orally Bioavailable Inhibitors of Lipoprotein-Associated Phospholipase A2
文献类型：期刊论文
| 作者 | Liu, Qiufeng1,2,4; Huang, Fubao3,4; Yuan, Xiaojing2,4; Wang, Kai3; Zou, Yi2; Shen, Jianhua3 ; Xu, Yechun2
|
| 刊名 | JOURNAL OF MEDICINAL CHEMISTRY
 |
| 出版日期 | 2017-12-28 |
| 卷号 | 60期号:24页码:10231-10244 |
| ISSN号 | 0022-2623 |
| DOI | 10.1021/acs.jmedchem.7b01530 |
| 文献子类 | Article |
| 英文摘要 | Lipoprotein-associated phospholipase A2 (Lp-PLA2) is a promising therapeutic target for atherosclerosis, Alzheimer's disease, and diabetic macular edema. Here we report the identification of novel sulfonamide scaffold Lp-PLA2 inhibitors derived from a relatively weak fragment. Similarity searching on this fragment followed by molecular docking leads to the discovery of a micromolar inhibitor with a 300-fold potency improvement. Subsequently, by the application of a structure-guided design strategy, a successful hit-to-lead optimization was achieved and a number of Lp-PLA2 inhibitors with single-digit nanomolar potency were obtained. After preliminary evaluation of the properties of drug-likeness in vitro and in vivo, compound 37 stands out from this congeneric series of inhibitors for good inhibitory activity and favorable oral bioavailability in male Sprague Dawley rats, providing a quality candidate for further development. The present study thus clearly demonstrates the power and advantage of integrally employing fragment screening, crystal structures determination, virtual screening, and medicinal chemistry in an efficient lead discovery project, providing a good example for structure-based drug design. |
| WOS关键词 | ACTIVATING-FACTOR ACETYLHYDROLASE ; ZINC-DEPENDENT INHIBITORS ; DIABETIC MACULAR EDEMA ; A(2) LP-PLA(2) ; DARAPLADIB ; DISEASE ; EVENTS ; HEPATOCYTES ; SUPERFAMILY ; BINDING |
| 资助项目 | National Key R&D Program of China[2016YFA0502301] ; National Key R&D Program of China[2017YFB0202604] ; National Natural Science Foundation of China[81422047] ; National Natural Science Foundation of China[81661148046] ; National Natural Science Foundation of China[81602963] ; National Natural Science Foundation of China[81673302] |
| WOS研究方向 | Pharmacology & Pharmacy |
| 语种 | 英语 |
| WOS记录号 | WOS:000419263400021 |
| 出版者 | AMER CHEMICAL SOC |
| 源URL | [http://119.78.100.183/handle/2S10ELR8/272350]  |
| 专题 | 药物发现与设计中心 中科院受体结构与功能重点实验室 新药研究国家重点实验室 |
| 通讯作者 | Shen, Jianhua; Xu, Yechun |
| 作者单位 | 1.ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 200031, Peoples R China; 2.Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, Shanghai 201203, Peoples R China; 3.Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Drug Discovery & Design Ctr, Shanghai 201203, Peoples R China; 4.Univ Chinese Acad Sci, Beijing 100049, Peoples R China |
| 推荐引用方式 GB/T 7714 | Liu, Qiufeng,Huang, Fubao,Yuan, Xiaojing,et al. Structure-Guided Discovery of Novel, Potent, and Orally Bioavailable Inhibitors of Lipoprotein-Associated Phospholipase A2[J]. JOURNAL OF MEDICINAL CHEMISTRY,2017,60(24):10231-10244. |
| APA | Liu, Qiufeng.,Huang, Fubao.,Yuan, Xiaojing.,Wang, Kai.,Zou, Yi.,...&Xu, Yechun.(2017).Structure-Guided Discovery of Novel, Potent, and Orally Bioavailable Inhibitors of Lipoprotein-Associated Phospholipase A2.JOURNAL OF MEDICINAL CHEMISTRY,60(24),10231-10244. |
| MLA | Liu, Qiufeng,et al."Structure-Guided Discovery of Novel, Potent, and Orally Bioavailable Inhibitors of Lipoprotein-Associated Phospholipase A2".JOURNAL OF MEDICINAL CHEMISTRY 60.24(2017):10231-10244. |
入库方式： OAI收割
来源：上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。